CVS/Centene Deal Could Portend Big ‘Grab’ for MA Assets
December 9, 2019
CVS Health Corp.’s new agreement to buy Centene Corp.’s Illinois health plan doesn’t fall under the “megadeal” category. But industry experts see broader implications as health care players large and small continue to jockey for position and focus on strengthening their footholds in Medicaid managed care and, especially, the lucrative Medicare Advantage (MA) program.
Just as PBMs were seen previously as “great acquisitive opportunities, now we think the next round of opportunity is grabbing as many MA plans as possible,” and being “opportunistic” when required divestitures in a given state come along, as in this case, Ashraf Shehata, KPMG’s national sector leader for health care and life sciences, tells AIS Health.